Holders over time
- EHC
- ELV
| Quarter | EHC | ELV |
|---|---|---|
| Q3 2020 | 10 holders, $1.3bn | 30 holders, $15.0bn |
| Q4 2020 | 11 holders, $1.6bn | 29 holders, $16.7bn |
| Q1 2021 | 13 holders, $1.2bn | 25 holders, $18.6bn |
| Q2 2021 | 16 holders, $1.2bn | 30 holders, $19.4bn |
| Q3 2021 | 18 holders, $1.3bn | 26 holders, $18.5bn |
| Q4 2021 | 13 holders, $1.2bn | 29 holders, $23.3bn |
| Q1 2022 | 12 holders, $1.4bn | 31 holders, $23.9bn |
| Q2 2022 | 12 holders, $1.2bn | 32 holders, $23.3bn |
| Q3 2022 | 13 holders, $914m | 34 holders, $22.6bn |
| Q4 2022 | 11 holders, $1.0bn | 34 holders, $25.5bn |
| Q1 2023 | 8 holders, $811m | 39 holders, $22.5bn |
| Q2 2023 | 14 holders, $1.4bn | 38 holders, $20.6bn |
| Q3 2023 | 16 holders, $1.3bn | 34 holders, $19.8bn |
| Q4 2023 | 11 holders, $1.3bn | 36 holders, $20.3bn |
| Q1 2024 | 14 holders, $1.7bn | 35 holders, $21.3bn |
| Q2 2024 | 10 holders, $1.5bn | 33 holders, $22.1bn |
| Q3 2024 | 14 holders, $1.8bn | 30 holders, $20.2bn |
| Q4 2024 | 17 holders, $1.8bn | 32 holders, $15.9bn |
| Q1 2025 | 11 holders, $1.8bn | 28 holders, $17.1bn |
| Q2 2025 | 16 holders, $2.1bn | 27 holders, $14.8bn |
| Q3 2025 | 21 holders, $2.6bn | 27 holders, $12.7bn |
| Q4 2025 | 17 holders, $2.4bn | 25 holders, $17.0bn |
| Q1 2026 | 17 holders, $2.0bn | 26 holders, $13.6bn |
| Q2 2026 | 13 holders, $2.0bn | 28 holders, $17.7bn |
Encompass Health Corp
- Holders
- 11
- Reported value
- $1.3bn
- Buyers
- 8
- Sellers
- 3
Breadth +5 among 93 comparable managers.
Elevance Health Inc Formerly
- Holders
- 36
- Reported value
- $20.3bn
- Buyers
- 10
- Sellers
- 27
Breadth -17 among 93 comparable managers.
Who holds both, Q4 2023
Both (7)
Arrowstreet Capital LP, Bridgewater Associates LP, Invesco Ltd, Janus Henderson Group Ltd, MFS Investment Management, Point72 Asset Management LP, Wellington Management Group LLP
Only EHC (4)
Capital Research Global Investors, Farallon Capital Management LLC, Holocene Advisors LP, PDT Partners LLC
Only ELV (29)
Acadian Asset Management LLC, AllianceBernstein LP, AQR Capital Management LLC, Artisan Partners LP, Baillie Gifford & Co, Citadel Advisors LLC, D. E. Shaw & Co., D1 Capital Partners LP, Dodge & Cox, ExodusPoint Capital Management LP, Fidelity (FMR LLC), First Eagle Investment Management LLC, Glenview Capital Management LLC, Man Group PLC, Marshall Wace LLP, Maverick Capital Ltd, Millennium Management LLC, Neuberger Berman Group LLC, Quantbot Technologies LP, Renaissance Technologies LLC, Ruane Cunniff & Goldfarb LP, Schonfeld Strategic Advisors LLC, Squarepoint Ops LLC, Steadfast Capital Management LP, T. Rowe Price Associates Inc, and 4 more
How much of the picture this is
A 13F is a manager’s long US-listed equity book at a quarter end, filed up to 45 days later. Buyers and sellers count comparable managers (those that filed both quarters) by shares, so a rise in value with no rise in shares is the price. Large books are listed to their largest positions. These are 95 tracked managers, not the institutional market.